Adalta Capital Management LLC Natera, Inc. Transaction History

Adalta Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$86.26 - $119.0 $86,260 - $119,000	-1,000 Closed	0 $0
Q2 2021 Aug 17, 2021	SELL	$86.05 - $119.72 $17,210 - $23,944	-200 Reduced 16.67%	1,000 $114,000
Q1 2021 May 18, 2021	SELL	$91.47 - $124.36 $137,205 - $186,540	-1,500 Reduced 55.56%	1,200 $122,000
Q4 2020 Feb 17, 2021	SELL	$66.66 - $111.74 $53,328 - $89,392	-800 Reduced 22.86%	2,700 $269,000
Q3 2020 Nov 17, 2020	BUY	$45.89 - $72.67 $160,615 - $254,345	3,500 New	3,500 $253,000

527

118M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $15.6B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Adalta Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Adalta Capital Management LLC with notifications on news.